DaVita HealthCare Partners Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DaVita HealthCare Partners Inc. on July 11, 2016. The report addresses corporate governance changes specifically regarding the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors expanded from 10 to 11 members.
- New Appointment: Phyllis R. Yale was appointed to fill the newly created seat on the Board.
- Compensation: Ms. Yale will receive standard compensation and indemnification applicable to all other non-employee directors, as detailed in the Proxy Statement filed on May 10, 2016.
Outlook, Risks, and Management Commentary
The filing confirms that no arrangement or understanding exists between Ms. Yale and any other person regarding her selection. Furthermore, the Company states it has not been a participant in any transaction since the beginning of its last fiscal year involving Ms. Yale or her immediate family that would constitute a material interest.
Key Facts for Investor Verification
- Verify the effective date of Phyllis R. Yale's appointment to the Board.
- Review the Proxy Statement filed on May 10, 2016, for details on the Non-Employee Director Compensation Policy.
- Confirm the total number of Board members is now 11.